Advertisement

Synjardy (empagliflozin and metformin) is used to lower blood sugar and treat type 2 diabetes. Synjardy is slightly less popular than other SGLT2 inhibitor/biguanide combinations. There are currently no generic alternatives to Synjardy.

Check our savings tips for co-pay cards, assistance programs, and other ways to reduce your cost. Synjardy is covered by some Medicare and insurance plans.

Savings Alert: We've added new, lower prices at most pharmacies for this prescription. Learn More

Synjardy Latest News

Get the latest updates on this drug from the GoodRx medical team

80+ Drugs to Be Dropped By Insurance in 2018

Elizabeth Davis - August 22, 2017

If you’ve got health insurance, now’s a good time to be paying attention. Each year, prescription coverage changes, and yours will likely be changing in 2018.

Express Scripts and Caremark, companies that handle pharmacy benefits for more than 200 million Americans, are removing more than 80 prescription medications from their formularies at the end of 2017. There is a silver lining for some of you though—almost 20 currently excluded drugs will be covered in 2018. See More

Top 10 New Drugs of 2015

Dr. Sharon Orrange - November 16, 2015

Pharmaceutical manufacturers released a number of new prescription drugs in 2015. Some of these new drugs are truly lifesavers . . . and some aren’t. Either way, pharmaceutical companies will be spending lots of money to let you know about them—you’ll be seeing them on the sides of buses and in TV commercials for quite a while.

As a doctor, I’m always excited about improvements that help patients. Some of the drugs below can really make a difference. See More

5 Ways to Save More on Your Diabetes Meds

Dr. Sharon Orrange - October 06, 2015

More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.
Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy